Unveiling Zyn’s Deceptive Marketing Tactics

In recent years, there has been a growing concern over the marketing practices of big tobacco companies and their impact on young consumers. One such concern is the alleged targeting of minors by Swedish Match North America and parent company Philip Morris International (PMI) through their oral nicotine product brand, Zyn.

The Schmidt National Law Group’s proposed class action lawsuit has shed light on the deceptive marketing tactics employed by these companies, issuing a legal battle to hold them accountable for their actions.

Philip Morris Seeks Dismissal of Zyn Injury Lawsuits in Florida Court

August 20, 2024 — In a recent legal maneuver, tobacco giant Philip Morris has petitioned a Florida court to dismiss a series of lawsuits related to injuries allegedly caused by its nicotine pouch product, Zyn. This development marks a significant turn in the ongoing litigation surrounding the controversial smokeless tobacco alternative.

New Legal Arguments Presented

Philip Morris’s legal team has introduced fresh arguments in their motion to dismiss, challenging the plaintiffs’ claims on several fronts. The company contends that:

1. Federal preemption: The lawsuits should be dismissed as they conflict with federal regulations governing tobacco products.
2. Lack of causation: Insufficient evidence links Zyn use directly to the alleged injuries.
3. Assumption of risk: Consumers were adequately warned about potential risks associated with nicotine products.

These arguments represent a strategic shift in Philip Morris’s defense strategy, potentially setting new precedents in tobacco-related litigation.

Background on Zyn and Previous Lawsuits

Zyn, a tobacco-free nicotine pouch, has gained popularity as an alternative to traditional smoking products. However, its rapid rise has been accompanied by concerns over health risks, particularly among young users. Previous lawsuits alleged that Philip Morris:

• Marketed Zyn aggressively to youth
• Downplayed potential health risks
• Failed to provide adequate warnings on packaging

Implications of the Court’s Decision

The Florida court’s ruling on this motion could have far-reaching consequences for both Philip Morris and the broader tobacco industry. If successful, the dismissal could:

• Set a precedent for similar cases nationwide
• Strengthen the position of nicotine pouch manufacturers in future litigation
• Potentially influence regulatory approaches to novel nicotine products

However, if the motion is denied, it could pave the way for a protracted legal battle and potentially costly settlements for Philip Morris.

Looking Ahead

As the court deliberates on Philip Morris’s motion, all eyes are on Florida. The decision could shape the future of Zyn and similar products in the U.S. market. Regardless of the outcome, this case underscores the ongoing tension between innovation in the tobacco industry and public health concerns.

Stakeholders on all sides will be closely monitoring developments, as the ruling could have significant implications for consumers, manufacturers, and regulators alike in the evolving landscape of nicotine products.

---

The Zyn Marketing Allegations

Our 35-page lawsuit, filed in the Southern District of California, filed March 1, 2024, accuses Swedish Match and PMI of purposefully marketing Zyn to children while downplaying the addictive and health risks associated with the product.

The Schmidt National Law Group attorneys argue that Zyn’s small nicotine pouches, resembling chewing gum, are marketed on social media and sold in enticing flavors like wintergreen, peppermint, spearmint, and cinnamon, specifically targeting underage buyers.

Furthermore, our lawsuit claims that the companies misleadingly advertise Zyn as “tobacco-free,” creating the impression that the product is less harmful or carries a reduced risk of addiction. While Zyn pouches do not contain tobacco leaves, they still derive their nicotine content from tobacco, making the “tobacco-free” claim deceptive.

Unveiling Zyn’s Deceptive Marketing Tactics

The Zyn class action lawsuit alleges that the marketing tactics employed by Swedish Match and PMI closely resemble those used by the tobacco industry in the past (JUUl Vape Pens). The aim, according to the suit, is to hook kids on nicotine while making them believe that it is not dangerous or harmful. By exploiting themes of independence, curiosity, and adventure, the companies create an allure around Zyn that appeals to adolescents.

Zyn – No FDA Approval

One particularly concerning aspect highlighted in our lawsuit is the failure of Swedish Match and PMI to obtain authorization from the U.S. Food and Drug Administration (FDA) to market Zyn pouches as a “modified risk tobacco product” or a “tobacco cessation device.” Despite this lack of approval, the nicotine concentration in Zyn pouches exceeds that found in other nicotine replacement therapies, potentially increasing the risk of addiction.

“A typical cigarette smoker absorbs 1mg of nicotine into the body per cigarette. Zyn’s own research shows that at its 3 mg nicotine concentration, 1.59 mg of nicotine per single pouch is absorbed into the body; at its 6 mg concentration, 3.51 mg of nicotine per pouch is absorbed; and at its 8 mg concentration, 3.79 mg of nicotine per pouch is absorbed. Zyn, therefore, delivers a potent dose of nicotine into the bloodstream.” – Zyn Class Action Lawsuit (COMPLAINT CASE NO.: 3:24-cv-00417-AGS-MMP)

The Zyn Health Risks for Children

Nicotine addiction poses significant health risks, particularly for young people whose brains are still developing. The lawsuit highlights the potential consequences of nicotine use during adolescence, including disruptions in brain circuit formation, attention, learning, and susceptibility to addiction. Research has shown that early nicotine use is correlated with daily use and lifetime nicotine dependence.

Moreover, the lawsuit emphasizes the various health risks associated with nicotine use, including increased stress levels, symptoms of depression and anxiety, cardiovascular, respiratory, and gastrointestinal conditions, suppressed immune response, and reproductive problems. By allegedly targeting minors with deceptive marketing, Swedish Match and PMI are accused of exposing young individuals to these potential health hazards.

Congress Regulatory Concerns over Zyn

The Zyn class action lawsuit has drawn attention not only from concerned consumers but also from regulatory bodies such as the FDA. In light of the allegations, the FDA is investigating the marketing strategies employed by Philip Morris for Zyn, raising concerns about potential teenage targeting, similar to what occurred with JUUL, another nicotine vape product.

The concerns expressed by the FDA have been echoed by members of Congress, including Senate Majority Leader Chuck Schumer, who has called for legislative and regulatory measures to restrict the marketing and sale of Zyn. Regulatory bodies in Belgium, Germany, and the Netherlands have already taken action, prohibiting the sale of nicotine pouch products like Zyn due to their perceived role as a “gateway” nicotine product for teenagers and young adults.

The Zyn Lawsuit’s Impact

Schmidt National Law Group’s potential Zyn class action lawsuit seeks to hold Swedish Match North America and parent company Philip Morris International accountable for their alleged deceptive marketing strategies and failure to adequately inform consumers about the risks of nicotine addiction. The outcome of this lawsuit could have significant implications for the future regulation of oral nicotine products and the protection of young consumers from targeted marketing.

Joining the Zyn Lawsuit, How to File a Zyn Claim

If you have purchased Zyn products in the United States, you may be eligible to join the proposed class action lawsuit. Typically, when a class action lawsuit is first filed, there is no immediate action required to join. However, if a class action settlement is reached, eligible class members will be notified by mail or email with instructions on how to participate.

Contact us today at 1-800-631-5656 to file your Zyn Lawsuit Claim today, or use the 100% secure intake form below.

Downplaying the addictive nature and health risks of Zyn

The Schmidt National Law Group’s Zyn class action lawsuit shines a light on the alleged deceptive marketing tactics used by Swedish Match and Philip Morris International to target minors with their oral nicotine product. By downplaying the addictive nature and health risks of Zyn, the companies are accused of exposing young individuals to potential harm. The outcome of this lawsuit could have far-reaching implications for the regulation of oral nicotine products and the protection of young consumers.

---

Attorney Martin Schmidt of The Schmidt National Law Group has taken action and has filed the first lawsuit against Swedish Match North America and parent Philip Morris International (PMI) in the Southern District California court for its oral nicotine product brand Zyn for marketing to children and failure to warn consumers. Read our full Press Release Here.

Zyn Class Action Lawsuit Attorneys Page Updated on August 20, 2024